Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment

British Journal of Surgery

Volumn 99, Issue 9, 2012, Pages 1227-1233

  Lu, W ^a,c   Greuter, M J W ^a   Schaapveld, M ^b   Vermeulen, K M ^a   Wiggers, T ^a   De Bock, G H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MASTECTOMY; METHODOLOGY; MIDDLE AGED; NETHERLANDS; PATIENT REFERRAL; POSTOPERATIVE CARE; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MASTECTOMY; MIDDLE AGED; NETHERLANDS; POSTOPERATIVE CARE; REFERRAL AND CONSULTATION; TREATMENT OUTCOME;

EID: 84864675636     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8850     Document Type: Article

References (33)

1. ASCO. Breast cancer facts and figures 2007-2008. Cancer Pract 2007; 8: 55.
2. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW,. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-1389.
3. Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, et al., Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009; 456: 1042-1066.
4. Peuckmann V, Ekholm O, Sjøgren P, Rasmussen NK, Christiansen P, Møller S, et al., Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer 2009; 45: 625-633.
5. Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M,. Future supply and demand for oncologists challenges to assuring access to oncology services. J Oncol Pract 2007; 3: 79-86. (Pubitemid 351593695)
6. Ganz PA, Hahn EE,. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol 2008; 26: 759-767. (Pubitemid 351264389)
7. Montgomery DA, Krupa K, Cooke TG,. Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer 2007; 96: 1625-1632. (Pubitemid 46847195)
8. Gulliford T, Opomu M, Wilson E, Hanham I, Epstein R,. Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study. BMJ 1997; 314: 174-177. (Pubitemid 27037868)
9. Kokko R, Hakama M, Holli K,. Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial. Breast Cancer Res Treat 2005; 93: 255-260. (Pubitemid 41441295)
10. Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, et al., Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 1999; 49: 705-710. (Pubitemid 29429964)
11. Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al., Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 2006; 24: 848-855. (Pubitemid 46638835)
12. Beaver K, Tysver-Robinson D, Campbell M, Twomey M, Williamson S, Hindley A, et al., Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ 2009; 338: a3147.
13. Grunfeld E,. Optimizing follow-up after breast cancer treatment. Curr Opin Obstet Gynecol 2009; 21: 92-96.
14. Jacobi CE, Nagelkerke NJ, van Houwelingen JH, de Bock GH,. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study. Cancer Epidemiol Biomarkers Prev 2006; 15: 429-436.
15. Greuter MJ, Jansen-van der Weide MC, Jacobi CE, Oosterwijk JC, Jansen L, Oudkerk M, et al., The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer risk. Eur J Cancer 2010; 46: 495-504.
16. Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL,. The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 2006; 36: 37-47.
17. Soerjomataram I, Louwman WJ, Duijm LE, Coebergh JW,. Rising incidence of breast cancer among female cancer survivors: implications for surveillance. Br J Cancer 2009; 100: 77-81.
18. Lu WL, Jansen L, Schaapveld M, Baas PC, Wiggers T, De Bock GH,. Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer 2011; 11: 279.
19. Fenton JJ, Rolnick SJ, Harris EL, Barton MB, Barlow WE, Reisch LM, et al., Specificity of clinical breast examination in community practice. J Gen Intern Med 2007; 22: 332-337. (Pubitemid 46941230)
20. Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S,. Breast cancer tumour growth estimated through mammography screening data. Breast Cancer Res 2008; 10: R41.
21. Houssami N, Miglioretti DL,. Early detection of breast cancer the second time around: mammography in women with a personal history of breast cancer. Med J Aust 2011; 194: 439-440.
22. Nederlandse Zorgautoriteit. National Health Tariffs. [accessed 1 June 2011].
23. Rijnsburger AJ,. Effects and Costs of Breast Cancer Screening in Women with a Familial or Genetic Predisposition (PhD thesis). Erasmus University: Rotterdam, 2005.
24. Flobbe K, Kessels AG, Severens JL, Beets GL, de Koning HJ, von Meyenfeld MF, et al., Costs and effects of ultrasonography in the evaluation of palpable breast masses. Int J Technol Assess Health Care 2004; 20: 440-448. (Pubitemid 39491491)
25. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FF,. Handbook for Cost-Studies: Methods and Unit Prices for Economic Evaluations in Health Care, Revised Version. Dutch Health Insurance Board: Diemen, 2004.
26. Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, et al., Routine follow up of breast cancer in primary care: randomised trial. BMJ 1996; 313: 665-669. (Pubitemid 26300604)
27. White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, et al., Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004; 96: 1832-1839. (Pubitemid 40081320)
28. Coldman AJ, Phillips N, Olivotto IA, Gordon P, Warren L, Kan L,. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia. J Med Screen 2008; 15: 182-187.
29. Montgomery DA, Krupa K, Cooke TG,. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 2007; 97: 1632-1641. (Pubitemid 350249350)
30. Soerjomataram I, Louwman WJ, Lemmens VE, de Vries E, Klokman WJ, Coebergh JW,. Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. Eur J Cancer 2005; 41: 2331-2337. (Pubitemid 41415610)
31. Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, et al., The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 2008; 110: 189-197. (Pubitemid 351793865)
32. Lu WL, Jansen L, Post WJ, Bonnema J, van de Velde CJ, de Bock GH,. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 2009; 114: 403-412.
33. Peer PG, Verbeek AL, Straatman H, Hendriks JH, Holland R,. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Treat 1996; 38: 153-160. (Pubitemid 26102142)